Anti-EGFR strategies for cancer treatment / 国际肿瘤学杂志

ABSTRACT

Epidermal growth factor receptor(EGFR) correlates closely with tumor genesis and progres-sion. Several agents targeting EGFR have been used in clinic, and achieved good effect in treatment of ad-vanced and drag-resistant tumors, such as monoclonal antibodies and small molecule tyrosine kinase inhihitors.